Project: A proteogenomic pipeline for capture and sequencing and production of pathogen-specific antibodies
| Acronym | PathoBody (Reference Number: 115025) |
| Duration | 01/04/2021 - 01/04/2024 |
| Project Topic | The consortium will implement a fast platform for the recovery of pathogen-specific antibody molecules from exposed patients. High value monoclonal antibody leads derived from Covid-19 patients will be the first output. In addition, the novel combination of NGS, phage display, and proteomics pioneered in our project will be the basis of an offer to industrial parties that wish to develop high value human antibodies against other pathogens and to have a response capability in future pandemics. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 14 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Erasmus MC | Partner | Netherlands |
| 2 | GenXPro GmbH | Partner | Germany |
| 3 | Pubgene A.S. | Coordinator | Norway |